Literature DB >> 29129085

Radiation techniques for esophageal cancer.

Minsi Zhang1, Abraham J Wu2.   

Abstract

Radiotherapy plays a crucial role in the curative management of localized esophageal cancer, both as definitive and preoperative therapy. For definitive therapy, the standard radiation dose is 50.4 Gy in 28 fractions and should be delivered with concurrent chemotherapy. Chemoradiotherapy also has a wellestablished benefit in the preoperative setting, as established in the CROSS randomized trial. Radiation fields are typically generous, to account for subclinical extension of disease along the esophagus and to regional nodes. Three-dimensional conformal radiation is the current standard technique for esophageal cancer, though intensity-modulated radiation therapy is increasingly utilized and may improve the outcomes of esophageal radiotherapy by reducing radiation dose to critical normal tissues.

Entities:  

Keywords:  Esophageal cancer; intensity modulated radiation therapy; radiation dose; radiotherapy; target volume delineation

Mesh:

Year:  2017        PMID: 29129085     DOI: 10.21037/cco.2017.06.33

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  6 in total

1.  Impact of Regional Lymph Node Irradiation on Reducing Lymph Node Recurrence in Esophageal Cancer Patients.

Authors:  Shigenobu Watanabe; Ichiro Ogino; Daisuke Shigenaga; Masaharu Hata
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Retrospective analysis of the bleeding risk induced by oral antiplatelet drugs during radiotherapy.

Authors:  Dan Xi; Wenjie Jiang; Yingjie Shao; Xing Song; Yuan Chen; Mengjiao Liu; Wendong Gu; Qilin Li
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

3.  Association between tumor morphology and dosimetric parameters of organs at risk after intensity-modulated radiotherapy in esophagus cancer.

Authors:  Fahui Li; Yuxuan Luo; Jing Chen; Liping He; Yiying Liang; Junjie Lai; Feibao Guo
Journal:  J Appl Clin Med Phys       Date:  2022-05-30       Impact factor: 2.243

4.  Anlotinib Inhibits Tumor Angiogenesis and Promotes the Anticancer Effect of Radiotherapy on Esophageal Cancer through Inhibiting EphA2.

Authors:  Zhenlin Gu; Weiguo Zhu; Wanwei Wang; Yingying Xu; Lei Jiang; Jiasheng Huang; Jing Huang
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

5.  Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy.

Authors:  Cong Wang; Ming Lu; Tingting Zhou; Shasha Zhao; Shanghui Guan
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

6.  Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway.

Authors:  Hangjie Ying; Min Fang; Qing Qing Hang; Yamei Chen; Xu Qian; Ming Chen
Journal:  J Cell Mol Med       Date:  2021-07-29       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.